By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
The litigation involved multiple civil lawsuits alleging anti-competitive practices and violations of federal
Analysts expect modest revenue growth but pressure on profitability in the March quarter
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
Muted movement reflects consolidation phase as investors await earnings triggers
The ninth edition of the event brought together over 800 delegates, more than 60 national and international speakers, and 20+ partner organisations across 10 sessions
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
At India Pharma 2026, Dr Bahl calls for experimentation over imitation as funding rises and translational ecosystem reforms gather pace
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
Subscribe To Our Newsletter & Stay Updated
